ERBB2 and breast carcinoma: Most breast cancer cells are estrogen receptor- (ER)/progesterone receptor (PR)-positive, with human epidermal growth factor receptor 2 (HER2)-negative (69%), and almost half of postmenopausal patients have ER-positive breast cancer cells [47,48].